Autologous Bone Marrow Mononuclear Cells
Sponsors
The University of Texas Health Science Center, Houston, Andalusian Network for Design and Translation of Advanced Therapies, National Cerebral and Cardiovascular Center, Japan, Shanghai Jiao Tong University School of Medicine, TotipotentRX Cell Therapy Pvt. Ltd.
Conditions
Acute Myocardial InfarctionAutistic DisorderBone Marrow Mononuclear CellsCerebral EmbolismCerebral PalsyDiabetesDiabetic FootIschemic Stroke
Phase 1
Safety/Feasibility of Autologous Mononuclear Bone Marrow Cells in Stroke Patients
CompletedNCT00859014
Start: 2009-01-31End: 2013-11-30Updated: 2015-01-01
Autologous Bone Marrow Derived Mononuclear Cells in Treating Diabetic Patients With Critical Limb Ischemia
CompletedNCT00872326
Start: 2007-12-31End: 2009-05-31Updated: 2014-11-14
Autologous Bone Marrow Mononuclear Cell Transplantation for Stroke Patients
CompletedNCT01028794
Start: 2008-05-31End: 2013-07-31Updated: 2013-07-08
Autologous Bone Marrow-Derived Mononuclear Cell Transplantation in Accelerating Tissue Expansion and Skin Regeneration
NCT01209611
Start: 2010-09-30End: 2014-12-31Target: 30Updated: 2014-04-22
Rapid Delivery of Autologous Bone Marrow Derived Stem Cells in Acute Myocardial Infarction Patients.
NCT01536106
Start: 2013-12-31End: 2015-03-31Target: 30Updated: 2013-09-04
Treatment of Severe Adult Traumatic Brain Injury Using Bone Marrow Mononuclear Cells
CompletedNCT01575470
Start: 2012-03-31End: 2015-05-31Updated: 2016-07-13
Autologous Bone Marrow Mononuclear Cells Therapy in Diabetic Lower Limb Ischemia
NCT01937416
Start: 2012-01-31End: 2014-12-31Target: 10Updated: 2013-12-04
Phase 2
Pediatric Autologous Bone Marrow Mononuclear Cells for Severe Traumatic Brain Injury
CompletedNCT01851083
Start: 2013-08-31End: 2020-10-12Updated: 2020-11-20
Outcomes of Stem Cells for Cerebral Palsy
CompletedNCT02569775
Start: 2014-04-30End: 2015-08-31Updated: 2015-10-16
Outcomes of Stem Cells for Cerebral Palsy
CompletedNCT02574923
Start: 2015-11-05End: 2018-04-30Updated: 2018-05-07
Autologous Bone Marrow Stem Cell Therapy for Autism
CompletedNCT02627131
Start: 2014-04-30End: 2015-12-31Updated: 2015-12-10